Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegaserod effects on gut transit in constipation and dyspepsia
NCT00277550Phase 4Withdrawn
- Sponsor
- Novartis
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of tegaserod in chronic idiopathic constipation (CIC), dyspepsia, sponsored by Novartis. Status: withdrawn.
02
Drugs
tegaserod
03
Conditions
chronic idiopathic constipation (CIC)dyspepsia
Beyond the preview
Go deeper on NCT00277550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00277550.